VentriPoint Diagnostics (VPT) Stock Statistics & Valuation Metrics

VentriPoint Diagnostics has a market cap or net worth of C$16.39M. The enterprise value is C$22.72.

VentriPoint Diagnostics has 192,877,940 shares outstanding. The number of shares has decreased by -2.65% in one year.

VentriPoint Diagnostics’s return on equity (ROE) is 0.78 and return on invested capital (ROIC) is 222.24%.

The current PE Ratio of VentriPoint Diagnostics is ―. VentriPoint Diagnostics’s PEG ratio is 0.19.

In the last 12 months, VentriPoint Diagnostics had revenue of 179.93K and earned -3.20M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was -1.92M and capital expenditures -5.00, giving a free cash flow of -1.92M billion.

VentriPoint Diagnostics pays an annual dividend of ―, resulting in a dividend yield of ―

VentriPoint Diagnostics upcoming earnings date is Dec 2, 2026, Before Open (Confirmed).

VentriPoint Diagnostics as a current ratio of 0.08, with Debt / Equity ratio of -68.25%

In the past 12 months, VentriPoint Diagnostics has paid -52.20K in taxes.

VentriPoint Diagnostics EV to EBITDA ratio is -9.64, with an EV/FCF ratio of -16.53.

VentriPoint Diagnostics has C$333.63K in cash and marketable securities with C$2.62M in debt, giving a net cash position of -C$2.28M billion.

Gross margin is 89.55%, with operating margin of -1889.37%, and net profit margin of -1778.62%.

The average price target for VentriPoint Diagnostics is ―, which is 11.43% higher than the current price. The consensus rating is ―